Anthrax: developing drugs for prophylaxis of inhalational anthrax
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Anthrax -- drug therapy Anthrax -- prevention & control Antibiotic Prophylaxis Clinical Trials as Topic Drug Evaluation, Preclinical -- standards Drugs, Investigational -- therapeutic use Inhalation Exposure Adult Child Endpoint Determination Microbial Sensitivity Tests -- standards Pediatrics Product Surveillance, Postmarketing -- standards Research Design Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Guideline Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (13 pages)).
- NLM Unique ID:
- 101734212 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101734212